These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3033999)

  • 1. Competitive inhibitor binding assay (CIBA) of ACE inhibitors.
    Grönhagen-Riska C; Tikkanen I; Fyhrquist F
    Acta Med Scand Suppl; 1986; 714():43-7. PubMed ID: 3033999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competitive inhibitor binding assay (CIBA) of captopril and other ACE inhibitors.
    Grönhagen-Riska C; Tikkanen I; Fyhrquist F
    Clin Chim Acta; 1987 Jan; 162(1):53-60. PubMed ID: 3026689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive inhibitor binding assay (IBA) of captopril and other inhibitors of angiotensin converting enzyme.
    Tikkanen FF; Grönhagen-Riska C
    Scand J Urol Nephrol Suppl; 1984; 79():13-6. PubMed ID: 6089313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competitive Inhibitor Binding Assay (IBA) of Captopril and Other Inhibitors of Angiotensin Converting Enzyme.
    Tikkanen FF; Grönhagen-Riska C
    Scand J Urol Nephrol; 1984 Jul; 18(sup79):13-16. PubMed ID: 27786018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitor binding assay for angiotensin-converting enzyme.
    Fyhrquist F; Tikkanen I; Grönhagen-Riska C; Hortling L; Hichens M
    Clin Chem; 1984 May; 30(5):696-700. PubMed ID: 6325041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme (ACE) inhibitor transport in human intestinal epithelial (Caco-2) cells.
    Thwaites DT; Cavet M; Hirst BH; Simmons NL
    Br J Pharmacol; 1995 Mar; 114(5):981-6. PubMed ID: 7780654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of angiotensin I converting enzyme inhibition in the heart.
    Kinoshita A; Urata H; Bumpus FM; Husain A
    Circ Res; 1993 Jul; 73(1):51-60. PubMed ID: 8389676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitor binding assay of rat serum angiotensin converting enzyme.
    Tikkanen I; Fyhrquist F; Forslund T
    Clin Sci (Lond); 1984 Aug; 67(2):237-41. PubMed ID: 6086211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two binding sites on angiotensin-converting enzyme: evidence from radioligand binding studies.
    Perich RB; Jackson B; Rogerson F; Mendelsohn FA; Paxton D; Johnston CI
    Mol Pharmacol; 1992 Aug; 42(2):286-93. PubMed ID: 1325031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface plasmon resonance analysis of the binding mechanism of pharmacological and peptidic inhibitors to human somatic angiotensin I-converting enzyme.
    Zidane F; Zeder-Lutz G; Altschuh D; Girardet JM; Miclo L; Corbier C; Cakir-Kiefer C
    Biochemistry; 2013 Dec; 52(48):8722-31. PubMed ID: 24168709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of angiotensin converting enzyme inhibitors in serum by radioinhibitor binding displacement assay.
    Jackson B; Cubela R; Johnston CI
    Biochem Pharmacol; 1987 Apr; 36(8):1357-60. PubMed ID: 3036166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative inhibitory potency and plasma drug levels of angiotensin converting enzyme inhibitors in the rat.
    Johnston CI; Cubela R; Jackson B
    Clin Exp Pharmacol Physiol; 1988 Feb; 15(2):123-9. PubMed ID: 2856050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Converting-enzyme inhibitors increase converting-enzyme mRNA and activity in endothelial cells.
    King SJ; Oparil S
    Am J Physiol; 1992 Oct; 263(4 Pt 1):C743-9. PubMed ID: 1329541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of angiotensin I-converting enzyme (ACE)-containing follicles in the rat ovary during the estrous cycle and effects of ACE inhibitor on ovulation.
    Daud AI; Bumpus FM; Husain A
    Endocrinology; 1990 Jun; 126(6):2927-35. PubMed ID: 2161740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid reversal of angiotensin converting enzyme inhibition by lisinopril in the perfused rabbit lung.
    Rimar S; Gillis CN
    Pulm Pharmacol; 1992 Jun; 5(2):103-9. PubMed ID: 1319250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors: measurement of relative inhibitory potency and serum drug levels by radioinhibitor binding displacement assay.
    Jackson B; Cubela R; Johnston CI
    J Cardiovasc Pharmacol; 1987 Jun; 9(6):699-704. PubMed ID: 2442537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme.
    Grinshtein SV; Binevski PV; Gomazkov OA; Pozdnev VF; Nikolskaya II; Kost OA
    Biochemistry (Mosc); 1999 Aug; 64(8):938-44. PubMed ID: 10498812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of angiotensin-converting enzyme inhibitors in the rat in perfused hindlimbs and in vivo.
    Nelissen-Vrancken MH; Leenders PJ; Bost JG; Struijker-Boudier HA; Smits JF
    Eur J Pharmacol; 1992 Jun; 217(1):49-55. PubMed ID: 1327817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lisinopril and captopril in the treatment of heart failure in older patients. Comparison of a long- and short-acting angiotensin-converting enzyme inhibitor.
    Giles TD; Fisher MB; Rush JE
    Am J Med; 1988 Sep; 85(3B):44-7. PubMed ID: 2844087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competitive inhibition of glycylsarcosine transport by enalapril in rabbit renal brush border membrane vesicles: interaction of ACE inhibitors with high-affinity H+/peptide symporter.
    Lin CJ; Akarawut W; Smith DE
    Pharm Res; 1999 May; 16(5):609-15. PubMed ID: 10350000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.